BNP Paribas Exane Raises Morgan Stanley (NYSE:MS) Price Target to $205.00

Morgan Stanley (NYSE:MS) had its target price raised by analysts at BNP Paribas Exane from $195.00 to $205.00 in a note issued to investors on Friday,MarketScreener reports. The firm presently has a “neutral” rating on the financial services provider’s stock. BNP Paribas Exane’s price objective would suggest a potential upside of 8.97% from the stock’s previous close.

A number of other equities analysts have also weighed in on MS. Argus boosted their target price on Morgan Stanley from $210.00 to $225.00 and gave the stock a “buy” rating in a research report on Thursday, April 16th. HSBC boosted their target price on Morgan Stanley from $153.00 to $177.00 and gave the stock a “hold” rating in a research report on Friday, April 17th. Weiss Ratings reissued a “buy (b-)” rating on shares of Morgan Stanley in a research report on Thursday, January 22nd. BMO Capital Markets boosted their target price on Morgan Stanley from $190.00 to $220.00 and gave the stock an “outperform” rating in a research report on Monday, April 20th. Finally, Rothschild & Co Redburn boosted their target price on Morgan Stanley from $171.00 to $183.00 and gave the stock a “neutral” rating in a research report on Friday, April 17th. Ten equities research analysts have rated the stock with a Buy rating and thirteen have assigned a Hold rating to the company’s stock. According to data from MarketBeat, the stock has an average rating of “Hold” and an average target price of $201.89.

Morgan Stanley Price Performance

Shares of NYSE:MS opened at $188.13 on Friday. Morgan Stanley has a fifty-two week low of $112.03 and a fifty-two week high of $194.59. The business has a 50-day simple moving average of $170.25 and a two-hundred day simple moving average of $171.90. The company has a debt-to-equity ratio of 3.39, a quick ratio of 0.81 and a current ratio of 0.81. The firm has a market cap of $297.50 billion, a price-to-earnings ratio of 17.04, a price-to-earnings-growth ratio of 1.42 and a beta of 1.19.

Morgan Stanley (NYSE:MS) last issued its earnings results on Wednesday, April 15th. The financial services provider reported $3.43 earnings per share for the quarter, topping analysts’ consensus estimates of $3.02 by $0.41. Morgan Stanley had a return on equity of 17.89% and a net margin of 14.65%.The business had revenue of $20.58 billion during the quarter, compared to analyst estimates of $19.23 billion. During the same quarter in the previous year, the firm earned $2.60 EPS. Morgan Stanley’s revenue was up 16.0% on a year-over-year basis. On average, analysts expect that Morgan Stanley will post 11.8 earnings per share for the current year.

Insider Activity

In other news, insider Daniel A. Simkowitz sold 14,690 shares of the company’s stock in a transaction dated Friday, April 17th. The shares were sold at an average price of $189.24, for a total transaction of $2,779,935.60. Following the completion of the sale, the insider owned 365,802 shares of the company’s stock, valued at $69,224,370.48. This represents a 3.86% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, insider Eric F. Grossman sold 11,118 shares of the company’s stock in a transaction dated Monday, April 20th. The shares were sold at an average price of $190.75, for a total transaction of $2,120,758.50. Following the sale, the insider directly owned 169,403 shares of the company’s stock, valued at $32,313,622.25. The trade was a 6.16% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold 110,444 shares of company stock valued at $20,665,049 in the last quarter. 0.17% of the stock is currently owned by insiders.

Institutional Investors Weigh In On Morgan Stanley

Several hedge funds and other institutional investors have recently made changes to their positions in MS. Purpose Unlimited Inc. bought a new position in shares of Morgan Stanley during the 4th quarter valued at approximately $25,000. Motiv8 Investments LLC bought a new position in shares of Morgan Stanley during the 4th quarter valued at approximately $25,000. Olistico Wealth LLC bought a new position in shares of Morgan Stanley during the 4th quarter valued at approximately $27,000. Lodestone Wealth Management LLC bought a new position in shares of Morgan Stanley during the 4th quarter valued at approximately $28,000. Finally, WFA of San Diego LLC bought a new position in shares of Morgan Stanley during the 2nd quarter valued at approximately $28,000. Hedge funds and other institutional investors own 84.19% of the company’s stock.

Key Stories Impacting Morgan Stanley

Here are the key news stories impacting Morgan Stanley this week:

• Positive Sentiment: MSIM launched a Stablecoin Reserves Portfolio (MSNXX) aimed at stablecoin issuers — a new money‑market/reserve solution that positions Morgan Stanley as a provider of regulatory‑aligned cash reserves for the growing payment‑stablecoin market. This is strategically important because it can win fee income, strengthen MS’s digital‑assets franchise and deepen client relationships in crypto. MS stablecoin reserves fund
• Positive Sentiment: Third‑party analyst activity is supportive: BNP Paribas Exane raised its price target on MS to $205 (from $195), citing upside vs. the share price — a clear vote of confidence that can help investor sentiment. BNP Paribas raises PT
• Positive Sentiment: Market commentary and research note coverage (Zacks, other outlets) continue to highlight MS as a solid momentum/dividend and growth play — reinforcing buy‑side interest in the wealth‑management and capital‑markets franchises that drive recurring revenue. Zacks momentum coverage
• Neutral Sentiment: Morgan Stanley expanded market infrastructure ties (e.g., added as an NZX clearing participant) and continues to show institutional product rollout — incremental business development but not immediately earnings‑material. NZX clearing participant
• Neutral Sentiment: MS has been cited across media coverage for analyst model updates and sector research (examples: packaged‑foods coverage updates, biopharma model tweaks). These signals illustrate active franchise research but don’t directly move MS’s revenues. MS analyst activity examples
• Negative Sentiment: Intraday weakness likely reflects profit‑taking/positioning and options‑oriented selling: Schaeffer and other options commentators recently highlighted bearish trades tied to MS, which can amplify short‑term downward pressure. Lower-than‑average volume today (per background data) also suggests a thinner market exacerbating small sell flows. Schaeffer options note

Morgan Stanley Company Profile

Morgan Stanley (NYSE: MS) is a global financial services firm headquartered in New York City. Founded in 1935 by Henry S. Morgan and Harold Stanley, the company provides a broad range of investment banking, securities, wealth management and investment management services to corporations, governments, institutions and individual investors. Leadership has been guided by a senior executive team and board of directors; James P. Gorman has served as the company’s chief executive and chairman in recent years.

The firm’s primary business activities are organized around three principal businesses: Institutional Securities, Wealth Management and Investment Management.